Md-711 (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 86 | 肺動脈性肺高血圧症 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-JapicCTI-194651 | 12/3/2019 | 05/03/2019 | MD-711 Phase 2/3 Study in PAH | MD-711 Phase 2/3 Study in Pulmonary Arterial Hypertension | Pulmonary arterial hypertension | Intervention name : MD-711 INN of the intervention : treprostinil Dosage And administration of the intervention : Inhaled admistration Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - | Mochida Pharmaceutical Co., Ltd. | NULL | pending | 18 | 75 | BOTH | 15 | Phase 2;Phase 3 | Japan |